SPRY Total Non-Current Liabilities
Ars Pharmaceuticals Inc · Total Non-Current Liabilities
SPRY Total Non-Current Liabilities
Latest reported$174.25Mperiod ending
SPRY FY Total Non-Current Liabilities ($4.21M → $174.25M)
Annual total non-current liabilities
High-resolution chart · PNG
SPRY total non-current liabilities history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Non-Current Liabilities (USD) |
|---|---|
| 174,249,000 | |
| 70,915,000 | |
| 36,999 | |
| 3,105,000 | |
| 84,528,000 | |
| 32,249,000 | |
| 3,324,000 | |
| 4,206,000 |